- 专利标题: CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN INFUSION CONTROL SYSTEM
-
申请号: PCT/CN2021/126014申请日: 2021-10-25
-
公开(公告)号: WO2023070247A1公开(公告)日: 2023-05-04
- 发明人: YANG, Cuijun
- 申请人: MEDTRUM TECHNOLOGIES INC.
- 申请人地址: 7F Building 8, No.200 Niudun Road, Pilot Free Trade Zone
- 专利权人: MEDTRUM TECHNOLOGIES INC.
- 当前专利权人: MEDTRUM TECHNOLOGIES INC.
- 当前专利权人地址: 7F Building 8, No.200 Niudun Road, Pilot Free Trade Zone
- 代理机构: J.Z.M.C. PATENT AND TRADEMARK LAW OFFICE
- 主分类号: A61B5/20
- IPC分类号: A61B5/20 ; A61M5/142 ; A61B5/145 ; A61M5/172
摘要:
A closed-loop artificial pancreas insulin infusion control system, including a detection module (100) configured to the current blood glucose level G; a program module (101), connected to the detection module (100), preset with a compound artificial pancreas algorithm, including a first algorithm and a second algorithm. The first algorithm is used to calculate the first insulin infusion amount I 1, the second algorithm is used to calculate the second insulin infusion amount I 2, and the compound artificial pancreas algorithm further optimises I 1 and I 2 to obtain the final insulin infusion amount I 3; and an infusion module (102), connected to the program module (101), the program module (101) sends the final insulin infusion amount I 3 to the infusion module (102), the infusion module (102) is configured to infuse insulin according to the final insulin infusion amount I 3. Through further optimisation of the first insulin infusion amount I 1 and the second insulin infusion amount I 2, the final infusion result is more accurate and reliable, realising precise control of the closed-loop artificial pancreatic insulin infusion control system.